Extracorporeal Membrane Oxygenation Market Size, Share, Trends, Value 2030

Extracorporeal Membrane Oxygenation Market

Extracorporeal Membrane Oxygenation Market By Modality (Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV)), By Application (Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030

Category: Healthcare Report Format : PDF Pages: 232 Report Code: ZMR-4986 Published Date: Aug-2023 Status : Published
Market Size in 2022 Market Forecast in 2030 CAGR (in %) Base Year
USD 10 Billion USD 15 Billion 7.1% 2022

Extracorporeal Membrane Oxygenation Market

Extracorporeal Membrane Oxygenation Industry Prospective:

The global extracorporeal membrane oxygenation market size was evaluated at $10 billion in 2022 and is slated to hit $15 billion by the end of 2030 with a CAGR of nearly 7.1% between 2023 and 2030.

Global Extracorporeal Membrane Oxygenation Market SizeRequest Free Sample

Extracorporeal Membrane Oxygenation Market: Overview

Extracorporeal membrane oxygenation (ECMO), which is also known as extracorporeal life support (ECLS), is a technique extra corporeally that provides sustained cardiovascular and respiratory support to patients whose heart as well as lungs cannot provide enough exchange to sustain life. ECMO's technology is largely derived from cardiopulmonary bypass, which provides suspended native circulation with short-term support. The ECMO machine replaces heart and lung functions. In the intensive care unit (ICU) of a hospital, patients who need help from an ECMO system are cared for. Usually, for only a few hours to days, people are assisted by an ECMO device but may need it for a few weeks depending on how their condition progresses.

Key Insights

  • As per the analysis shared by our research analyst, the global extracorporeal membrane oxygenation market is projected to expand annually at the annual growth rate of around 7.1% over the forecast timespan (2023-2030)
  • In terms of revenue, the global extracorporeal membrane oxygenation market size was evaluated at nearly $10 billion in 2022 and is expected to reach $15 billion by 2030.
  • The global extracorporeal membrane oxygenation market is anticipated to boost owing to the  increasing incidence of chronic obstructive pulmonary disorder (COPD), cardiopulmonary disease, and respiratory failure around the globe
  • In terms of modality, the venovenous (VV) segment is slated to register the highest CAGR over the analysis period.
  • Based on the application, the respiratory segment is anticipated to dominate the segment over the projected period.
  • Region-wise, the Asia-Pacific extracorporeal membrane oxygenation industry is projected to register the fastest CAGR during the assessment timeline.

Extracorporeal Membrane Oxygenation Market: Growth Factors

Rise in the cases of chronic obstructive pulmonary disorders to drive the global market growth by 2030

Increasing incidence of chronic obstructive pulmonary disorder (COPD), cardiopulmonary disease, and respiratory failure around the globe will provide significant potential for the global extracorporeal membrane oxygenation market in the forecast timeframe. According to the World Health Organization, chronic obstructive pulmonary disorder (COPD) affects around 65 million people annually, and nearly 3 million die each year worldwide due to the condition. Approximately 17.9 million people died in 2016 as a result of cardiovascular disease (CVD), accounting for around 31 percent of the world's total deaths. Increasing incidence of unhealthy habits, as well as tobacco smoking, would result in an increased incidence of respiratory disorders that will fuel market growth over the projected timespan. New product launches and strategic alliances will account majorly towards the expansion of the market in the upcoming years. For instance, in the first half of 2023, Getinge Group, a key healthcare firm based in Sweden, joined hands with Kinderherzen, a non-profit firm based in Sweden, to help children fight congenital heart disorders.  

Extracorporeal Membrane Oxygenation Market: Restraints

Rising costs of products can put brakes on the global industry expansion over 2023-2030

Huge prices of extracorporeal membrane oxygenation products can result in a decline in the sale of these products, thereby hindering the global extracorporeal membrane oxygenation industry expansion. Non-availability of funds for improving the healthcare infrastructure in remote areas can diminish the growth of industry across the globe.  

Extracorporeal Membrane Oxygenation Market: Opportunities

Rise in the number of hospitals offering extracorporeal membrane oxygenation services to patients to generate new opportunities for growth for the global market

The surging survival rate of patients due to extracorporeal membrane oxygenation treatment along with a rise in its acceptance in lung transplantation methods will open new growth avenues for the global extracorporeal membrane oxygenation market. An increase in the number of hospitals providing extracorporeal membrane oxygenation services will generate new facades of growth for the market globally over the upcoming years.

Extracorporeal Membrane Oxygenation Market: Challenges

Low availability of skilled workforce can put a challenge to the global industry surge over the forecast timeline 

The lack of availability of experts has put up a big challenge for the global extracorporeal membrane oxygenation industry in the coming years. Less availability of advanced healthcare facilities to patients in emerging economies can further shrink the growth of the industry across the globe.  

Extracorporeal Membrane Oxygenation Market: Segmentation

The global extracorporeal membrane oxygenation market is sectored into modality, application, and region.    

In modality terms, the global extracorporeal membrane oxygenation market is segregated into venovenous (VV), venoarterial (VA), and arteriovenous (AV) segments. Furthermore, the venovenous (VV) segment, which garnered nearly 57% of the global market share in 2022, is predicted to record the highest CAGR in the ensuing years. The growth of the segment in the upcoming years can be due to the rise in cases of respiratory failure, increasing lung transplants, and advances in healthcare technologies.

Based on application, the global extracorporeal membrane oxygenation industry is bifurcated into cardiac, respiratory, and extracorporeal cardiopulmonary resuscitation (ECPR) segments. Moreover, the cardiac segment, which accounted sizably for the global industry revenue in 2022, is set to register the fastest CAGR over the forecast timespan. The segmental expansion over the estimated timeline can be subject to the surge in the cases of cardiac surgeries in countries such as the U.S. along with humungous awareness about the benefits of using extracorporeal membrane oxygenation machines in cardiac surgery.

Extracorporeal Membrane Oxygenation Market: Report Scope

Report Attributes Report Details
Report Name Extracorporeal Membrane Oxygenation Market
Market Size in 2022 USD 10 Billion
Market Forecast in 2030 USD 15 Billion
Growth Rate CAGR of 7.1%
Number of Pages 232
Key Companies Covered EUROSETS S.r.l, Getinge Group, ALung Technologies Inc., Sorin Group, XENIOS AG, MAQUET Holding B.V. & Co. KG, OriGen Biomedical Inc., NIPRO Medical Corporation, Terumo Corporation, Medos Medizintechnik AG, Medtronic plc, LivaNova PLC., and others.
Segments Covered By Modality, By Application, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Extracorporeal Membrane Oxygenation Market: Regional Insights

North America is projected to maintain its global market domination over the estimated timeframe

North America, which accounted for 65% of the global extracorporeal membrane oxygenation market revenue in 2022, will be the dominating region over the assessment timeline. Moreover, the regional market growth can be credited to favorable reimbursement scenario, increased incidence of lung cancer, and the availability of a large number of ECMO centers in the U.S. Apart from this, new product launches and the presence of key players in the region will further drive the regional market trends. A surge in chronic disorders and the easy availability of modern healthcare amenities to patients will upsurge the growth of the market in the region.

Global Extracorporeal Membrane Oxygenation Market ShareRequest Free Sample

The Asia-Pacific extracorporeal membrane oxygenation industry is set to register the fastest CAGR in the next couple of years subject to the rise in healthcare spending by the government and entrepreneurs. Economic growth in countries such as India and China coupled with supportive government policies associated with healthcare such as the construction of hospitals with improved healthcare services at reasonable costs and a large number of beds will spur the regional industry growth.

Extracorporeal Membrane Oxygenation Market: Competitive Space

The global extracorporeal membrane oxygenation market profiles key players such as:

  • EUROSETS S.r.l
  • Getinge Group
  • ALung Technologies Inc.
  • Sorin Group
  • XENIOS AG
  • MAQUET Holding B.V. & Co. KG
  • OriGen Biomedical Inc.
  • NIPRO Medical Corporation
  • Terumo Corporation
  • Medos Medizintechnik AG
  • Medtronic plc
  • LivaNova PLC.

The global extracorporeal membrane oxygenation market is segmented as follows:

By Modality

  • Venoarterial (VA)
  •  Venovenous (VV)
  • Arteriovenous (AV)

By Application

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Extracorporeal membrane oxygenation (ECMO), which is also known as extracorporeal life support (ECLS), is a technique extra corporeally that provides sustained cardiovascular and respiratory support to patients whose heart as well as lungs cannot provide enough exchange to sustain life.    

The global extracorporeal membrane oxygenation market growth can be owing to the adoption of profitable business strategies such as new product launches and strategic alliances by firms to expand their business portfolio, regional presence, and profits.

According to a study, the global extracorporeal membrane oxygenation industry size was $10 billion in 2022 and is projected to reach $15 billion by the end of 2030.

The global extracorporeal membrane oxygenation market is anticipated to record a CAGR of nearly 7.1% from 2023 to 2030.

The Asia-Pacific extracorporeal membrane oxygenation industry is set to register the highest CAGR over the forecasting timeline owing to a rise in healthcare spending by the government and entrepreneurs. Economic growth in countries such as India and China coupled with supportive government policies associated with healthcare such as the construction of hospitals with improved healthcare services at reasonable costs and a large number of beds will spur the regional industry growth.

The global extracorporeal membrane oxygenation market is led by players such as EUROSETS S.r.l, Getinge Group, ALung Technologies Inc., Sorin Group, XENIOS AG, MAQUET Holding B.V. & Co. KG, OriGen Biomedical Inc., NIPRO Medical Corporation, Terumo Corporation, Medos Medizintechnik AG, Medtronic plc, and LivaNova PLC.

The extracorporeal membrane oxygenation market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed